Proposed algorithm to investigate latent and occult viruses in vaccine cell substrates by chemical induction

Biologicals

Volumn 37, Issue 3, 2009, Pages 196-201

  Khan, Arifa S ^a   Ma, Wenbin ^a   Ma, Yunkun ^a   Kumar, Anita ^a   Williams, Dhanya K ^a   Muller, Jacqueline ^a   Ma, Hailun ^a   Galvin, Teresa A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Chemical inducers; Latent viruses; Vaccine cell substrates; Virus activation

Indexed keywords

AZACITIDINE; BUTYRIC ACID; CELL DNA; IDOXURIDINE; PHORBOL 13 ACETATE 12 MYRISTATE; RESIDUAL CELL DNA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ALGORITHM; ANIMAL CELL; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; INFLUENZA; LATENT VIRUS INFECTION; LICENSING; MOUSE; NONHUMAN; OCCULT VIRUS; PANDEMIC; PRIORITY JOURNAL; RETROVIRUS; SAFETY; VACCINE PRODUCTION; VIRUS ACTIVATION; VIRUS DETECTION; VIRUS INDUCTION;

ALGORITHMS; VACCINES; VIRUSES;

DNA VIRUSES; RNA VIRUSES;

EID: 67349119272     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.02.016     Document Type: Article

References (21)

1. http://www.fda.gov/ohrms/dockets/ac/cber05.html#VaccinesandRelatedBiolog ical; [assessed 16.11.05].
2. Points to consider for the characterization of cell lines used to produce. Biologicals (July 12, 1993)
3. Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. September, 2006.
4. Boeke J.D., and Stoye J.P. Retrotransposons, endogenous retroviruses, and the evolution of retroelements. In: Coffin J., Hughes S.H., and Varmus H. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 343-435
5. Brown P.O. Integration. In: Coffin J., Hughes S.H., and Varmus H. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 161-203
6. Coffin J.M. Endogenous viruses. In: Weiss R., Teich N., Varmus H., and Coffin J. (Eds). RNA tumor viruses. 2nd ed. Vol. 1 (1984), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1109-1203
7. Yu Y., Black J.B., Goldsmith C.S., Browning P.J., Bhalla K., and Offermann M.K. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol 80 (1999) 83-90
8. Khan A.S. Retrovirus screening of vaccine cell substrates. In: Brown F., and Lubiniecki A.S. (Eds). Developments in biological standardization: viral safety and evaluation of viral clearance from biopharmaceutical products Vol. 88 (1996), Karger, Basel 155-160
9. Khan A.S., Muller J., and Sears J.F. Early detection of endogenous retroviruses in chemically-induced mouse cells. Virus Res 79 (2001) 39-45
10. Bierley S.T., Raineri R., Poiley J.A., and Morgan E.M. A comparison of methods for the estimation of retroviral burden. Dev Biol Stand 88 (1996) 163-165
11. Arnold B.A., Hepler R.W., and Keller P.M. One-step fluorescent probe product-enhanced reverse transcriptase assay. Biotechniques 25 (1998) 98-106
12. Maudru T., and Peden K.W. Adaptation of the fluorogenic 5′-nuclease chemistry to a PCR-based reverse transcriptase assay. Biotechniques 25 (1998) 972-975
13. Lovatt A., Black J., Galbraith D., Doherty I., Moran M.W., Shepherd A.J., et al. High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. J Virol Methods 82 (1999) 185-200
14. Sears J.F., and Khan A.S. Single-tube fluorescent product-enhanced reverse transcriptase assay with Ampliwax (STF-PERT) for retrovirus quantitation. J Virol Methods 108 (2003) 139-142
15. Khan A.S., Maudru T., Thompson A., Muller J., Sears J.F., and Peden K.W.C. The reverse transcriptase activity in cell-free medium of chicken embyro fibroblast cultures is not associated with a replication-competent retrovirus. J Clin Virol (1998) 7-18
16. Lugert R., Köonig H., Kurth R., and Tönjes R.R. Specific suppression of false-positive signals in the product-enhanced reverse transcriptase assay. Biotechniques 20 (1996) 210-217
17. Maudru T., and Peden K. Elimination of background signals in a modified polymerase chain reaction-based reverse transcriptase assay. J Virol Methods 66 (1997) 247-261
18. Vogt V.M. Retroviral virions and genomes. In: Coffin J., Hughes S.H., and Varmus H. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 27-69
19. Lesser J., Lasneret J., Canivet M., Emanoil-Ravier R., and Périès J. Simultaneous activation by 5-azacytidine of intracisternal R particles and murine intracisternal-A particle related sequences in Syrian hamster cells. Virology 155 (1986) 249-256
20. Petricciani J. Historic overview of new substrates for vaccine development. Biologicals, in this issue.
21. Sheng-Fowler L, Lewis AM, Peden K. Issues associated with residual cell-substrate DNA in vaccines. Biologicals, 2009;37:190-5.